| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/12/2006 | WO2006041855A3 Compositions and methods using apocynin compounds and nitric oxide donors |
| 10/12/2006 | WO2006040688A3 Inhibitors of acetylcholinesterase for treating skin diseases |
| 10/12/2006 | WO2006039792A8 Method of treating autoimmune diseases |
| 10/12/2006 | WO2006033888A3 A process to treat avascular necrosis (avn) with osteoinductive materials |
| 10/12/2006 | WO2006031348A3 Mitotic kinesin inhibitors |
| 10/12/2006 | WO2006028742A3 Methods and conpositions for inhibition of innate immune responses and autoimmunity |
| 10/12/2006 | WO2006025070A3 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 10/12/2006 | WO2006022954A3 Benzoureas having anti-diabetic activity |
| 10/12/2006 | WO2006020999A3 Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform |
| 10/12/2006 | WO2006020049A3 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 10/12/2006 | WO2006010591A3 Quinazoline derivatives |
| 10/12/2006 | WO2006007136A3 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
| 10/12/2006 | WO2006006161A3 Improved process for the preparation of oxidized phospholipids |
| 10/12/2006 | WO2006002382A3 Arrays with cleavable linkers |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005120496A3 TREATING LEARNING DEFICITS WITH INHIBITORS OF HMG CoA REDUCTASE |
| 10/12/2006 | WO2005118592A8 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 10/12/2006 | WO2005117954A3 Compositions and methods for treatment of neovascular diseases |
| 10/12/2006 | WO2005117854A3 Aryl ketone compounds and compositions for delivering active agents |
| 10/12/2006 | WO2005115380B1 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
| 10/12/2006 | WO2005107763A3 Radiopharmaceutical and methods of synthesis and use thereof |
| 10/12/2006 | WO2005105753A8 Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 10/12/2006 | WO2005105087A3 Methods of diminishing co-abuse potential |
| 10/12/2006 | WO2005097113A3 5-ht2b receptor antagonists |
| 10/12/2006 | WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 10/12/2006 | WO2005092297A3 A stable pharmaceutical composition comprising an acid labile drug |
| 10/12/2006 | WO2005092030A3 Methods of use of bcl-6-derived nucleotides to induce apoptosis |
| 10/12/2006 | WO2005089729A3 Galenic formulations of organic compounds |
| 10/12/2006 | WO2005032459A3 Erythrosin-based antimicrobial photodynamic therapy compound and its use |
| 10/12/2006 | WO2005030132A3 Therapeutic regimens for administering drug combinations |
| 10/12/2006 | WO2005007149A8 Ambroxol for treating acute pains |
| 10/12/2006 | WO2002098389A8 Method of forming an aerosol for inhalation delivery |
| 10/12/2006 | US20060230467 Plant deoxyribonucleoside kinase enzymes and their use |
| 10/12/2006 | US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 10/12/2006 | US20060229588 Irrigation solution and method for inhibition of pain and inflammation |
| 10/12/2006 | US20060229470 Calcium receptor-active molecules |
| 10/12/2006 | US20060229456 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents |
| 10/12/2006 | US20060229455 Bicyclic [3.1.0.] heteroaryl amides as type 1 glycine transport inhibitors |
| 10/12/2006 | US20060229449 Reacting with chloramine in presence of aqueous base, phase transfer catalyst; anti-cancer agents, kinase inhibitors |
| 10/12/2006 | US20060229447 Constrained compounds as CGRP-receptor antagonists |
| 10/12/2006 | US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 10/12/2006 | US20060229368 Medical application of oxidized monoterpenes |
| 10/12/2006 | US20060229366 Method for preventing or treating respiratory infections in infants |
| 10/12/2006 | US20060229365 Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions |
| 10/12/2006 | US20060229364 Antiviral compositions and methods of use |
| 10/12/2006 | US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds |
| 10/12/2006 | US20060229362 N-(3-substituted-4-cyano)phenyl-2-hydroxy-2-methyl-3-(4-cyano)phenoxy propamides; spermatogenesis inhibitors, hormone replacement therapy, anticarcinogenic, antiproliferative agents for prostate cancer, apoptotic agents; bone and muscle disorders |
| 10/12/2006 | US20060229361 Prodrugs of GABA analogs, compositions and uses thereof |
| 10/12/2006 | US20060229360 Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined Vitamins C and K3 |
| 10/12/2006 | US20060229359 Tocopherol-modified therapeutic drug compounds |
| 10/12/2006 | US20060229358 Pharmaceutical composition containing flavonoids |
| 10/12/2006 | US20060229357 Compounds |
| 10/12/2006 | US20060229356 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions |
| 10/12/2006 | US20060229355 3.3'-Diindolylmethane compositions inhibit angiogenesis |
| 10/12/2006 | US20060229354 Use of Isatin in stimulating red blood cell production and treatment of anemia |
| 10/12/2006 | US20060229353 Substituted heterocycles |
| 10/12/2006 | US20060229352 asenapine synthesis, a schizophrenia drug |
| 10/12/2006 | US20060229351 2-Substituted-1 H-benzimidazile-4-carboxamides are PARP inhibitors |
| 10/12/2006 | US20060229350 Losartan potassium crystalline form alpha |
| 10/12/2006 | US20060229349 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 10/12/2006 | US20060229348 Oxindole oxazolidinone as antibacterial agent |
| 10/12/2006 | US20060229347 Treatment of eczemas |
| 10/12/2006 | US20060229346 Method for treating vascular hyperpermeable disease |
| 10/12/2006 | US20060229345 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 10/12/2006 | US20060229344 Method of treating amyotrophic lateral sclerosis |
| 10/12/2006 | US20060229343 Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists |
| 10/12/2006 | US20060229342 TNF-a production inhibitors |
| 10/12/2006 | US20060229341 Peptide deformylase inhibitors |
| 10/12/2006 | US20060229340 Composition for improving cognition and memory |
| 10/12/2006 | US20060229339 Novel use of substituted aminomethyl chromans |
| 10/12/2006 | US20060229338 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 10/12/2006 | US20060229337 Certain substituted amides, method of making, and method of use thereof |
| 10/12/2006 | US20060229336 HIV, acquired immune deficiency syndrome (AIDS); 1-(8-{2-[1-(2,2-Dimethylpropanoyl)-4-phenylpiperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole |
| 10/12/2006 | US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| 10/12/2006 | US20060229334 Biphenyl derivatives |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | US20060229332 crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or solvate thereof; treating disease associated with 5-HT4 receptor activity; gastrointestinal tract disorder |
| 10/12/2006 | US20060229331 Ketoprofen compositions and methods of making them |
| 10/12/2006 | US20060229330 4-aminopyrimidine-5-one derivatives |
| 10/12/2006 | US20060229329 Such as 2-anilino-4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)pyrimidine; antiproliferative agents; rheumatoid arthritis |
| 10/12/2006 | US20060229326 For therapy and prophylaxis of diseases which are associated with the modulation of cannabinoid receptors (CB1), such as obesity |
| 10/12/2006 | US20060229325 Cancer therapy, auto-immune diseases, such as psoriasis, alopecia and multiple sclerosis; chemotherapy agent-induced alopecia and mucositis; cardiovascular diseases, such as stenoses, arterioscieroses and restenoses; infectious diseases, such as, e.g., those caused by unicellular parasites |
| 10/12/2006 | US20060229324 Quinazolin-4-one derivatives |
| 10/12/2006 | US20060229323 (3,4-Dihydro-quinazolin-2-yl)-indan-1-yl-amines |
| 10/12/2006 | US20060229322 Anhydrous crystalline form of valacyclovir hydrochloride |
| 10/12/2006 | US20060229321 Rosuvastatin in pre demented states |
| 10/12/2006 | US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 10/12/2006 | US20060229319 For treatment of allergies; antihistamines |
| 10/12/2006 | US20060229318 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 10/12/2006 | US20060229317 Substituted heterocyclic compounds |
| 10/12/2006 | US20060229316 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | US20060229314 5-oxo-7-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-4,5-dihydro-thieno[3,2-b]pyridine-6-carbonitrile; angiogenesis antagonist; antitumor, antiinflammatoy agent; indirect inhibition of cytokines, growth factors, chemokines, and lymphokines |
| 10/12/2006 | US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 10/12/2006 | US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 10/12/2006 | US20060229311 Isatine derivatives with neurotrophic activity |
| 10/12/2006 | US20060229310 Antibacterial compounds |
| 10/12/2006 | US20060229309 N-((1R,2S)-3-(3,5-difluorophenyl)-1-hydroxy-1-((2R,4R)-4-propoxypyrrolidin-2-yl)propan-2-yl)-3-((R)-2-(methoxymethyl)pyrrolidine-1-carbonyl)-5-(oxazol-2-yl)benzamide, used to prevent the accumulation of amyloid protein deposits in the brain; treatment of Alzheimer's disease and Down's Syndrome |
| 10/12/2006 | US20060229308 Substituted pyrirmidin-4-ylamine analogues as vanilloid receptor ligands |
| 10/12/2006 | US20060229307 partial antagonists and partial agonists of vanilloid-1 receptor (VR1); N-(4-trifluoromethylphenyl)-2-(3-trifluoromethyl-2-pyridinyl)pyrido[2,3-d]pyridazin-5-amine; antiinflammatory and analgesic agent |